Known targets — ChEMBL curated mechanism
CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D
The experimentally established mechanism targets of Benzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | DAO | P14920 | 1/20 | 0.56 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.56 |
| ▸ | CES2 | O00748 | 4/20 | 0.52 |
| ▸ | CES1 | P23141 | 4/20 | 0.52 |
| ▸ | RARB | P10826 | 4/20 | 0.49 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.48 |
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzoic Acid SCHEMBL10613339 | 0.94 | TSHR (0.54) | TSHRDAONAPRTCES2CES1 | |
| Benzoic Acid SCHEMBL28784335 | 0.92 | CES2 (0.54) | TSHRDAONAPRTCES2CES1 | |
| Hexadecylamine SCHEMBL11239719 | 0.92 | CES2 (0.54) | TSHRDAONAPRTCES2CES1 | |
| Decylamine SCHEMBL11437273 | 0.92 | CES2 (0.54) | TSHRDAONAPRTCES2CES1 | |
| Octadecylamine SCHEMBL11431528 | 0.92 | CES2 (0.54) | TSHRDAONAPRTCES2CES1 | |
| Dodecylamine SCHEMBL5968297 | 0.92 | CES2 (0.54) | TSHRDAONAPRTCES2CES1 | |
| Benzoic Acid SCHEMBL28250016 | 0.92 | CES2 (0.54) | TSHRDAONAPRTCES2CES1 | |
| Tetradecylamine SCHEMBL235412 | 0.92 | CES2 (0.54) | TSHRDAONAPRTCES2CES1 | |
| Benzoic Acid SCHEMBL7627648 | 0.92 | CES2 (0.54) | TSHRDAONAPRTCES2CES1 | |
| Terephthalic Acid SCHEMBL21599100 | 0.92 | RARB (0.56) | TSHRRARBTP53PLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3935114-B1 | PROTECTIVE COATING COMPOSITION AND COATED METALLIC SUBSTRATE COMPRISING SAME | MOMENTIVE PERFORMANCE MAT INC (US) | 2025-07-16 | — | — | EP | claimed |
| US-9365596-B2 | Method for preparing quaternary phosphonium salts | MICROVAST POWER SYSTEMS CO., LTD. (CN) | 2016-06-14 | — | — | US | claimed |
| US-20150166587-A1 | METHOD FOR PREPARING QUATERNARY PHOSPHONIUM SALTS | MICROVAST POWER SYSTEMS CO., LTD. (CN) | 2015-06-18 | — | — | US | claimed |
| EP-0553351-B1 | CRYSTALLINE MODIFICATION OF HYDROCHLORIDE OF 2-DIMETHYLAMINOETHYL ETHER OF n-BUTYLAMINO BENZOIC ACID, METHOD OF OBTAINING IT AND PHARMACEUTICAL PREPARATION FOR ANESTHESIA OF THE EYE BASED THEREUPON | LEONIDOV NIKOLAI B (RU) | 1995-12-27 | — | — | EP | claimed |
| EP-3416176-B1 | ELECTROLYTE SOLUTION FOR ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR UTILIZING SAID ELECTROLYTE SOLUTION | SANYO CHEMICAL IND LTD (JP) | 2026-01-07 | — | — | EP | disclosed |
| US-20250320381-A1 | POLISHING COMPOSITION, POLISHING METHOD, AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE | FUJIMI INCORPORATED (JP) | 2025-10-16 | — | — | US | disclosed |
| US-20250282977-A1 | POLISHING COMPOSITION, POLISHING METHOD, AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE | FUJIMI INCORPORATED (JP) | 2025-09-11 | — | — | US | disclosed |
| WO-2024090362-A1 | CHARGE-TRANSPORTING COMPOSITION | 日産化学株式会社 | 2024-05-02 | — | — | WO | disclosed |
| EP-3271411-B1 | POLYISOCYANATES CONTAINING SILANE GROUPS BASED ON 1,5-DIISOCYANATOPENTANE | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2024-01-10 | — | — | EP | disclosed |
| EP-3480835-B1 | ELECTROLYTIC SOLUTION FOR ELECTROLYTIC CAPACITOR, AND ELECTROLYTIC CAPACITOR | SANYO CHEMICAL IND LTD (JP) | 2022-12-21 | — | — | EP | disclosed |
| US-11527365-B2 | Electrolytic solution for electrolytic capacitor, and electrolytic capacitor | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2022-12-13 | — | — | US | disclosed |
| US-11424078-B2 | Electrolytic solution for electrolytic capacitor, and electrolytic capacitor | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2022-08-23 | — | — | US | disclosed |
| EP-0246825-B1 | QUATERNARY SALT SOLUTION ELECTROLYTE FOR ELECTROLYTIC CAPACITORS | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1991-02-27 | — | — | EP | disclosed |
| EP-0381936-A1 | An electrolyte for use in electrolytic capacitors | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1990-08-16 | — | — | EP | disclosed |
| EP-0350698-A2 | An improved method for curing silicone coatings on plastic substrates, and curable compositions related thereto | GENERAL ELECTRIC COMPANY (US) | 1990-01-17 | — | — | EP | disclosed |
| US-4892944-A | Process for producing quaternary salts | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1990-01-09 | — | — | US | disclosed |
| EP-0291074-A2 | Process for producing quaternary salts | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1988-11-17 | — | — | EP | disclosed |
| US-4774011-A | Electrolyte for aluminum electrolytic capacitor | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1988-09-27 | — | — | US | disclosed |
| US-4715976-A | QUATERNARY AMMONIUM SALT OF CARBOXYLIC ACID IN APROTIC SOLVENT | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1987-12-29 | — | — | US | disclosed |
| EP-0227433-A2 | Electrolyte solution of quaternary ammonium salt for electrolytic capacitor | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1987-07-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150166587-A1 | METHOD FOR PREPARING QUATERNARY PHOSPHONIUM SALTS | PHPT1, PHOSPHO1, PTEN | TSHR 2677/4885DAO 1566/4885NAPRT 1680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.